TH 9619 disodium salt

Pricing Availability   Qty
说明: MTHFD2 inhibitor
化学名: Disodium N-[[5-[[2-(2,4-Diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)acetyl]amino]-3-fluoro-2-pyridinyl]carbonyl]-L-glutamate
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for TH 9619 disodium salt

TH 9619 disodium salt is a potent and selective methylenetetrahydrofolate dehydrogenase inhibitor (MTHFD2; IC50 = 47 nM). It shows efficacity on HL-60 cell viability with EC50 of 11nM. In vitro, It shows antiproliferative efficacy in acute myeloid leukemia (AML) cells and T-ALL Jurkat cells. In vivo, TH9619 disodium salt impairs cancer progression in a mouse disease model of AML.

许可信息

Sold under license from Thomas Helleday's Foundation for Medical Research and One-Carbon Therapeutics

技术数据 for TH 9619 disodium salt

分子量 495.33
公式 C17H16FN7Na2O7
储存 Store at -20°C
纯度 ≥98% (HPLC)
InChI Key AKIUEXPYEGJOLL-WWPIYYJJSA-L
Smiles NC1=NC(C(CC(NC2=CN=C(C(F)=C2)C(N[C@H](C(O[Na])=O)CCC(O[Na])=O)=O)=O)=C(N1)N)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for TH 9619 disodium salt

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 9.91 20 温和加热

制备储备液 for TH 9619 disodium salt

以下数据基于产品分子量 495.33。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.2 mM 10.09 mL 50.47 mL 100.94 mL
1 mM 2.02 mL 10.09 mL 20.19 mL
2 mM 1.01 mL 5.05 mL 10.09 mL
10 mM 0.2 mL 1.01 mL 2.02 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for TH 9619 disodium salt

参考文献 for TH 9619 disodium salt

参考文献是支持产品生物活性的出版物。

Bonagas et al (2022) Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress. Nat.Cancer 3 156 PMID: 35228749


If you know of a relevant reference for TH 9619 disodium salt, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Other Dehydrogenase Inhibitors

关键词: TH 9619 disodium salt, TH 9619 disodium salt supplier, TH9619, inhibitors, inhibits, potent, selective, acute, myeloid, leukemia, AML, cancer, , in, vivo, Other, Dehydrogenases, 7719, Tocris Bioscience

篇 TH 9619 disodium salt 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 TH 9619 disodium salt 的引用文献。 您是否知道使用了 Tocris TH 9619 disodium salt 的优秀论文? 请告知我们.

TH 9619 disodium salt 的评论

目前没有该产品的评论。 Be the first to review TH 9619 disodium salt and earn rewards!

Have you used TH 9619 disodium salt?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cancer Metabolism Research Product Guide

Cancer Metabolism Research Product Guide

This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:

Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.